[HTML][HTML] RNA-based therapeutics: current developments in targeted molecular therapy of triple-negative breast cancer

S Haque, K Cook, G Sahay, C Sun - Pharmaceutics, 2021 - mdpi.com
Triple-negative breast cancer (TNBC) is a highly heterogeneous and aggressive cancer that
has the highest mortality rate out of all breast cancer subtypes. Conventional clinical …

[HTML][HTML] Development of cyclic peptides targeting the epidermal growth factor receptor in mesenchymal triple-negative breast cancer subtype

N Nisticò, A Aloisio, A Lupia, AM Zimbo, S Mimmi… - Cells, 2023 - mdpi.com
Triple-negative breast cancer (TNBC) is an aggressive malignancy characterized by the lack
of expression of estrogen and progesterone receptors and amplification of human epidermal …

Metformin inhibits the tumor-promoting effect of low-dose resveratrol, and enhances the anti-tumor activity of high-dose resveratrol by increasing its reducibility in triple …

T Cheng, C Wang, Q Lu, Y Cao, W Yu, W Li… - Free Radical Biology …, 2022 - Elsevier
Resveratrol, a natural antioxidant that maintains better bioactivity under hypoxia, has anti-
tumor effects, but its underlying mechanism is controversial and the effect on Triple-negative …

[HTML][HTML] Correlation between the Warburg effect and progression of triple-negative breast cancer

S Liu, Y Li, M Yuan, Q Song, M Liu - Frontiers in Oncology, 2023 - frontiersin.org
Triple-negative breast cancer (TNBC) is ineligible for hormonal therapy and Her-2-targeted
therapy due to the negative expression of the estrogen receptor, progesterone receptor, and …

[HTML][HTML] Machine learning analysis identifies genes differentiating triple negative breast cancers

C Kothari, MA Osseni, L Agbo, G Ouellette… - Scientific reports, 2020 - nature.com
Triple negative breast cancer (TNBC) is one of the most aggressive form of breast cancer
(BC) with the highest mortality due to high rate of relapse, resistance, and lack of an effective …

Ganglioside GD2: a novel therapeutic target in triple‐negative breast cancer

C Shao, V Anand, M Andreeff… - Annals of the New York …, 2022 - Wiley Online Library
Triple‐negative breast cancer (TNBC) is a heterogeneous disease characterized by lack of
hormone receptor expression and is known for high rates of recurrence, distant metastases …

[HTML][HTML] Transcytosable peptide-paclitaxel prodrug nanoparticle for targeted treatment of triple-negative breast cancer

L Wang, C Zhao, L Lu, H Jiang, F Wang… - International Journal of …, 2023 - mdpi.com
Triple-negative breast cancer (TNBC) is an extremely aggressive subtype associated with a
poor prognosis. At present, the treatment for TNBC mainly relies on surgery and traditional …

CircEGFR reduces the sensitivity of pirarubicin and regulates the malignant progression of triple-negative breast cancer via the miR-1299/EGFR axis

J Ma, C Chen, Z Fan, Y Zhang, J Ji, D Wei… - International Journal of …, 2023 - Elsevier
Circular RNAs (circRNAs) have been found to be involved in cancer progression and
chemotherapy sensitivity. However, the biological function of circRNAs in triple-negative …

[HTML][HTML] Long noncoding RNA AFAP1-AS1 promotes tumor progression and invasion by regulating the miR-2110/Sp1 axis in triple-negative breast cancer

X Zhang, F Li, Y Zhou, F Mao, Y Lin, S Shen, Y Li… - Cell Death & …, 2021 - nature.com
Long noncoding ribonucleic acids (LncRNAs) have been found to be involved in the
proliferation, apoptosis, invasion, migration, and other pathological processes of triple …

Artificial intelligence in breast imaging: potentials and challenges

J Li, D Sheng, J Chen, C You, S Liu… - Physics in Medicine & …, 2023 - iopscience.iop.org
Artificial intelligence in breast imaging: potentials and challenges Page 1 Physics in Medicine
& Biology ACCEPTED MANUSCRIPT • OPEN ACCESS Artificial intelligence in breast …